Celebration of Humanity
Our commitment is to make a meaningful impact on people’s lives Benefiting from genetic science through preventive and personalized wellness
Each individual is different from how we think to how we look like, how we live each day and what language we speak, however when we look at our genes, we share the same for almost 99%. Based on this genetic fact, we shall praise humanity, cherish it and through genetic testing, create a healthy society, which celebrates diversity. Genesis Healthcare holds this as its mission.
|Company Name||Genesis Healthcare Co.|
|Incorporation||March 1, 2004|
|Paid-in-Capital||¥3,778,192,002 (Including additional paid-in-capital)|
|Business Licence||Approval for Third-Class Production and Distribution of Medical Devices|
|Registrated Industry||Medical Device Manufacturing
Registered Public Health Laboratory
- Hematological Testing (Germline Gene Testing, Somatic Gene Testing)
|Member Organizations||CPIGI (Council for Protection of Individual Genetic Information)
Japan Bioindustry Association
|Location (Headquarters)||Yebisu Garden Place Tower 15F/26F 4-20-3 Ebisu, Shibuya-ku, Tokyo, JAPAN, 150-6026 (Main Reception: 15F)
TEL 03-5422-8506 FAX 03-5422-8526
|Laboratory||Yebisu Garden Place Tower 26F 4-20-3 Ebisu, Shibuya-ku, Tokyo, JAPAN, 150-6026|
Genesis Healthcare Asia Pte. Ltd.
|Chairman of the Board||David Baran (Founder)|
|President and Chief Strategy and Research||Dr. Iri Sato Baran (Co-Founder)|
|Chief Technology Officer||Takeru Miyahara|
|External Director||Tetsu Kayama|
|External Director||Dr. Kozo Denpo (DHC Corporation)|
|External Director||Kazuhiko Shibata|
|External Director||Hiroshi Mikitani (Rakuten, Inc.)|
|External Director||Matthew J. Burlage|
|Special Advisor||Toshiharu Furukawa, Doctor of Medical Science / Attorney-At-Law|
|Advisor||Nobuaki Tanaka, Doctor of Medicine|
|Medical Science Advisor||Shohei Matsuzaki (Tokai University Professor Emeritus)|
|2004.03||Founded by David Baran and Dr. Iri Sato-Baran.|
|2004.09||Started Gene Therapy Research & Development.|
|2005.03||Started providing Genetic Testing Services for Medical and Academic Institutions.|
|2008.06||Launch of Direct-To-Consumer Testing Service ‘GeneLife’.|
|2010.09||Obtained Japan Patent for Gene Therapy.|
|2011.03||Surpassed 100,000 tests.|
|2011.04||Established Genesis Institutes for Genetic Research to expand in-house research.|
|2011.08||Obtained International Patent for Gene Therapy.|
|2012.02||Commenced Online/EC Testing Services.|
|2012.05||Launched a directly operated Direct to Consumer Brand called ‘GeneLife’ that is targeted for mainly Japanese and Asians.|
|2012.06||Surpassed 200,000 kits sold.
Commenced DNA Banking Services.
|2012.07||Started conducting quantitative test for Periodontal Bacteria|
|2012.12||Launched ‘GeneLife2012’, the first microcrray-based DTC product.
Obtained Medical Device Manufacturing License and Medical Device Distribution License.
|2013.04||‘GeneLife’ Online services and apps become available on smartphone.|
|2013.06||Surpassed 300,000 kits sold.|
|2013.09||Start of GIGR (Cancer / GWAS) Services, an online testing kit for medical facilities|
|2013.12||Launched GeneLife Haplo.|
|2014.03||Launched ‘GeneLife Zero’, a comprehensive DTC kit commemorating the Anniversary of 10th year.|
|2014.05||Launched AR Genetic testing kit.|
|2014.09||Launched ‘GeneLife NEO’ Genetic testing kit.|
|2014.10||Launched Myself Genetic testing kit.
Affiliation with Genesis Medical Clinic Roppongi, the first Genetic Test Focused Private Clinic in Japan.
|2015.06||Surpassed 400,000 kits sold.|
|2015.07||Third Party allotment of new shares with approximately 620 million yen underwritten by MITSUI & CO. and Founders Fund.
Tezuka Osamu Genetic Analysis Project, a leading Manga artist in Japan.
Launched ‘GeneLife Genesis’ Genetic testing kit.
Launched Television Commercials on major networks in Japan.
|2015.08||Launch of BRCA1/2 Familial Breast Cancer test as a screening test to medical institutions in Japan.|
|2015.11||Expansion of Consumer genetic testing services to Asian Countries.|
|2016.06||‘GeneLife’ was granted accreditation by ‘CPIGI (Council for Protection of Individual Genetic Information)’.|
|2016.10||Surpassed 500,000 kits sold.|
|2017.04||Office and laboratory move to Yebisu Garden Place.|
|2017.08||Third Party allotment of new shares with approximately 1.4 billion yen underwritten by Rakuten.|
|2017.09||Launch ‘GeneLife Genesis2.0’ to examine about 1,400 genes at about 360 items at once.|
|2017.10||Launch genetic testing member service ‘GeneLife Premium’.|
|2018.02||Reached third-party equity allocation agreement with Rakuten Inc., and Omron Healthcare, Co.,Ltd.; an astounding amount of 1.65 Billion JPN Yen.|
|2018.06||Surpassed the threshold of 600,000 total number of analyses conducted|
|2018.10||Launch of the ‘Genesis Asia 1000’ Project, a project aiming to assemble a data base
specialized in Japanese and the Asian population.
Introduced whole genome sequencing services.